# Efficacy and Safety of TF002 in Cutaneous Mastocytosis

> **NCT00457288** · PHASE2 · COMPLETED · sponsor: **JADO Technologies GmbH** · enrollment: 30 (estimated)

## Conditions studied

- Cutaneous Mastocytosis

## Interventions

- **DRUG:** TF 002

## Key facts

- **NCT ID:** NCT00457288
- **Lead sponsor:** JADO Technologies GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457288, "Efficacy and Safety of TF002 in Cutaneous Mastocytosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00457288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*